Anti-arrhythmic Agents Flashcards
What is the best treatment for an asymptomatic or minimally symptomatic arrhythmia
No pharmacological treatment
what are use or state-dependent work
drugs that are more effective in blocking channels that are being used frequently (activated) or in an inactivated state (have a higher affinity for activated for inactive channels and low affinity for resting channels)
What is the MOA of the class I anti-arrhythmic agents
Na+ channel blockers
What is the MOA of the class II anti-arrhythmic agents
B-adrenergic receptor blocker
What is the MOA of the class III anti-arrhythmic agents
prolong action potential duration (K+ channel blocker)
What is the MOA of the class IV anti-arrhythmic agents
Ca++ channel blockers
What are the 3 drugs in the class 1A AAA
procainamide, quinidine, disopyramide (Intermediate kinetics)
what are the 2 drugs in the class 1B AAA
LIDOCAINE, mexiletine (Fast Kinetics)
What are the 3 drugs in the class 1C AAA
amiodarone, dronedarone, sotalol (Slow kinetics)
What is the MOA of propranolol
BB (class II)
What is the MOA of esmolol
BB (class II)
What is the MOA of amiodarone
prolong APD (K+ channel blocker)
What is the MOA of dronedarone
prolong APD (K+ channel blocker)
What is the MOA if sotalol
prolong APD (K+ channel blocker)
what is the MOA of verpamil
CCB (class IV)
what is the MOA of diltiazem
CCB (class IV)
what is the MOA of procainamide
blocks Na+ and K+ channels (intermediate kinetics - prolong APD)
What is the clinical effect of procainamide
slows upstroke of AP and conduction, prolong QRS, direct depressant action on SA/AN nodes use/state-dependent action
Indication for procainamide
atrial and ventricular arrhythmias, 2nd choice for ventricular arrhythmias post aMI